πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 40 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12378231

Small molecules as monoacylglycerol lipase (MAGL) inhibitors, compositions and use thereof

APOGEE PHARMACEUTICALS, INC. Β· Granted Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12303551

Cellular immunotherapy compositions and uses thereof

Cero Therapeutics Holdings, Inc. Β· Granted Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12291557

Chimeric TIM4 receptors and uses thereof

Cero Therapeutics Holdings, Inc. Β· Granted Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12215322

Treatment of liver disease with mitochondrial glycerol-3-phosphate acyltransferase (GPAM)

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12215321

Modulators of diacyglycerol acyltransferase 2 (DGAT2)

Ionis Pharmaceuticals, Inc. Β· Granted Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11877989

Nutritional supplement containing L-Ξ±-glycerophosphorylcholine

Energy Beverages LLC Β· Granted Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11708423

Chimeric engulfment receptor molecules and methods of use

Cero Therapeutics Holdings, Inc. Β· Granted Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11702701

Means and methods for staging, typing and treating a cancerous disease

UniversitΓ€t Regensburg Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11697689

Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential

INSTITUT DE CANCEROLOGIE DE L'OUEST Β· Granted Tue Jul 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11655282

Chimeric engulfment receptor molecules

Cero Therapeutics Holdings, Inc. Β· Granted Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11376247

Tyrosine kinase inhibitors regenerate non-cancerous tissue after cancer therapy

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11312962

Modulators of diacyglycerol acyltransferase 2 (DGAT2)

Ionis Pharmaceuticals, Inc. Β· Granted Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10675246

Orally administrable compositions comprising calcium

CEROLIFE LLC Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10668161

Therapeutic hyperbranched polyglycerol encapsulated biomolecules

The Regents of the University of California Β· Granted Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10519247

Targeting HER2 and HER3 with bispecific antibodies in cancerous cells

The Board of Regents of the University of Texas System Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10307410

Mcl-1 modulating compounds for cancer treatment

INSTITUT DE CANCEROLOGIE DE L'OUEST RENE GAUDUCHEAU Β· Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10273307

Humanized anti-CD134 (OX40) antibodies and uses thereof

Biocerox Products B.V. Β· Granted Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9790281

Humanized anti-CD134 (OX40) antibodies and uses thereof

Biocerox Products B.V. Β· Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9624170

4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitor

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9523691

Use of the olfactomedin-4 protein (OLFM4) in colorectal cancer diagnosis

INSTITUT DE CANCEROLOGIE DE L'OUEST Β· Granted Tue Dec 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9475880

Anti-CD134 (OX40) antibodies and uses thereof

Biocerox Products B.V. Β· Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9463193

Individual 5-fluorouracile dose optimization in folfiri treatment

INSTITUT DE CANCEROLOGIE DE L'OUEST Β· Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9457030

Compositions and methods for the treatment of juvenile neuronal ceroid lipofuscinosis and

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9271962

Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of can

Northwestern University Β· Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted